Sort
4,870 grants matching “glp 1”
Brain systems and behaviors underlying response to obesity treatment in children
$670,979Christian Ludwig Roth · Seattle Children'S Hospital · R01 · FY2021 · DK
Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma
$670,756Timothy A Marlowe · Faknostics, Llc · R42 · FY2022 · CA
Increased Protein at Breakfast for Weight Management in Overweight Adolescents
$670,673Heather J Leidy · Purdue University · R01 · FY2017 · DK
Modulation of cancer induced immune suppression via inhibition of SCD1
$670,441Karen E Hayes · Modulation Therapeutics, Inc. · R44 · FY2024 · CA
Third generation liver-directed dual-function AAT vectors
$670,000Christian Mueller · Univ Of Massachusetts Med Sch Worcester · P01 · FY2018 · HL
Human antibodies for therapeutic intervention of staph enterotoxin B exposure
$669,795Luigi Grasso · Morphotek, Inc. · U01 · FY2009 · AI
Affordable oral delivery of human blood protein drugs bioencapsulated in plant cells
$668,568Henry Daniell · University Of Pennsylvania · R01 · FY2018 · HL
Bumped-Kinase Inhibitor Drug Development for Toxoplasmosis
$668,478Wesley C Van Voorhis · University Of Washington · R01 · FY2024 · HD
Novel pharmacotherapy strategies for obesity in schizophrenia
$668,461Lars Fredrik Jarskog · Univ Of North Carolina Chapel Hill · R01 · FY2017 · DK
Development of a first-in-class antifungal agent to treat Candidiasis and Candidemia
$668,118Terry Roemer · Johns Hopkins University · U19 · FY2025 · AI
Development of RNAi based sFLT1-targeting therapeutics for treatment of Preeclampsia
$667,335Anastasia Khvorova · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · HD
Prostanoid modulators that reduce brain injury and inflammation after seizures
$666,225Raymond J Dingledine · Emory University · U01 · FY2009 · NS
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases
$665,919Aaron Richard McCabe · Minnetronix, Inc. · R42 · FY2018 · CA
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with Prediabetes
$665,637Absalon Dennis Gutierrez · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · DK
Image-guided Bariatric Arterial Embolization (BAE) for the Treatment of Obesity
$663,314Dara L Kraitchman · Johns Hopkins University · R01 · FY2024 · DK
Cardiovascular effects of GLP-1 in obesity/metabolic syndrome
$663,167Johnathan D Tune · Indiana University Indianapolis · R01 · FY2016 · HL
PRESERVATION OF BETA CELL FUNCTION IN PREDIABETES: IGT AND IFG
$663,044Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2021 · DK
PRESERVATION OF BETA CELL FUNCTION IN PREDIABETES: IGT AND IFG
$663,044Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2018 · DK
PRESERVATION OF BETA CELL FUNCTION IN PREDIABETES: IGT AND IFG
$663,044Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2019 · DK
Optimization of a Combined Drug and Delivery Device for Treatment of Cyanide Poisoning
$662,943Steven E Patterson · University Of Minnesota · U01 · FY2022 · NS
Cardiovascular effects of GLP-1 in obesity/metabolic syndrome
$662,933Johnathan D Tune · Indiana University Indianapolis · R01 · FY2015 · HL
Core--Development and analysis of SOD/Catalase mimetics
$661,885Susan Doctrow · Medical College Of Wisconsin · U19 · FY2009 · AI
Long-Term Islet Function and Impact after Total Pancreatectomy with Islet Autotransplant (LIFT)
$661,358Melena D. Bellin · University Of Minnesota · R01 · FY2021 · DK
Novel Inhibitors of Lysine Methyltransferases G9a and GLP for the Treatment of Alzheimer's Disease
$661,299Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG
Virtual systemic identification of drug targets of obesity candidate genes
$661,107Yingchang Lu · Vanderbilt University Medical Center · R01 · FY2025 · DK